PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34572484-0	2021	Growth Suppression in Lung Cancer Cells Harboring EGFR-C797S Mutation by Quercetin.	Quercetin	73-82	epidermal growth factor receptor	Homo sapiens	50-54	
34572484-5	2021	As quercetin was recently shown to inhibit AXL, quercetin may be effective in treating NSCLC cells harboring the EGFR C797S mutation.	Quercetin	48-57	epidermal growth factor receptor	Homo sapiens	113-117	
34572484-6	2021	In this work, the cytotoxic effects of quercetin and its ability to inhibit tumor growth were examined in TKI-resistant NSCLC cells harboring the EGFR C797S mutation.	Quercetin	39-48	epidermal growth factor receptor	Homo sapiens	146-150	
34572484-7	2021	We demonstrated that quercetin exhibited potent cytotoxic effects on NSCLC cells harboring the EGFR C797S mutation by inhibiting AXL and inducing apoptosis.	Quercetin	21-30	epidermal growth factor receptor	Homo sapiens	95-99	
34572484-8	2021	Quercetin inhibited the tumor growth of xenografted NSCLC cells harboring the EGFR C797S mutation and appeared to act synergistically with brigatinib to inhibit of tumor growth in vivo.	Quercetin	0-9	epidermal growth factor receptor	Homo sapiens	78-82	
34572484-9	2021	In summary, herein, we revealed that quercetin is an effective inhibitor for the treatment of non-small-cell lung cancer harboring the EGFR C797S mutation.	Quercetin	37-46	epidermal growth factor receptor	Homo sapiens	135-139